🇮🇳IN
Sign In
VI

VIVIMEDLAB

NSE

Vivimed Labs Ltd

₹6.09

-0.12(-1.93%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

VIVIMEDLAB financial summary

For Mar 2026, Vivimed Labs Ltd reported revenue of ₹56 crore, which fell 46.2% from the previous year. Net profit was -₹172 crore, on an operating margin of -269%. Earnings per share came in at -₹20.7. Annual results are available for 15 financial years, from Mar 2012 to Mar 2026.

Revenue₹56 crore
Net profit-₹172 crore
Operating margin-269%
EPS-₹20.7

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer